THE Malaysian healthcare sector is riddled with challenges. While some underlying issues have existed long before the pandemic, Covid-19 brought the complexities of the healthcare sector to the forefront.
Years of underinvestment in public healthcare – only 2.2% of gross domestic product (GDP) compared to 4.1% of GDP for upper middle-income countries in 2021 (according to World Health Organisation data) – have strained an already unsustainable financing model, taking a toll on the entire system.
